Pilot RCT in 20 women with cognitive impairment after breast cancer treatment: methylphenidate vs placebo for 28 days was feasible, with more improvement in FACT-Cog perceived impairment at day 29 (difference 10.1, P=0.02); neuropsychological tests did not differ.
RCTn = 20
Boivin et al. Positive Effect of Methylphenidate for Cancer-Related Cognitive Impairment: A Pilot Randomized Trial